BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35329847)

  • 1. The Nephrologist's Role in the Collaborative Multi-Specialist Network Taking Care of Patients with Diabetes on Maintenance Hemodialysis: An Overview.
    Cavallari G; Mancini E
    J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PATHOPHYSIOLOGY AND MANAGEMENT OF HYPOGLYCEMIAIN END-STAGE RENAL DISEASE PATIENTS: A REVIEW.
    Gianchandani RY; Neupane S; Iyengar JJ; Heung M
    Endocr Pract; 2017 Mar; 23(3):353-362. PubMed ID: 27967230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of teneligliptin in addition to insulin therapy in type 2 diabetes mellitus patients on hemodialysis evaluated by continuous glucose monitoring.
    Yajima T; Yajima K; Hayashi M; Takahashi H; Yasuda K
    Diabetes Res Clin Pract; 2016 Dec; 122():78-83. PubMed ID: 27810689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of the glycemic control and therapeutic regimen for diabetes mellitus in the Japanese patients on hemodialysis.
    Sanai T; Tada H; Ono T; Fukumitsu T
    Diabetes Metab Syndr; 2015; 9(4):244-6. PubMed ID: 25866098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Glycemic Effect of Liraglutide Evaluated by Continuous Glucose Monitoring in Persons with Type 2 Diabetes Receiving Dialysis.
    Bomholt T; Idorn T; Knop FK; Jørgensen MB; Ranjan AG; Resuli M; Hansen PM; Borg R; Persson F; Feldt-Rasmussen B; Hornum M
    Nephron; 2021; 145(1):27-34. PubMed ID: 33105146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interdialytic weight gain and survival in hemodialysis patients: effects of duration of ESRD and diabetes mellitus.
    Kimmel PL; Varela MP; Peterson RA; Weihs KL; Simmens SJ; Alleyne S; Amarashinge A; Mishkin GJ; Cruz I; Veis JH
    Kidney Int; 2000 Mar; 57(3):1141-51. PubMed ID: 10720966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Making sense of glucose sensors in end-stage kidney disease: A review.
    Williams ME; Steenkamp D; Wolpert H
    Front Clin Diabetes Healthc; 2022; 3():1025328. PubMed ID: 36992784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with DPP-4 inhibitors and insulin in patients with type 2 diabetes mellitus: what is the evidence?
    Charbonnel B; Schweizer A; Dejager S
    Hosp Pract (1995); 2013 Apr; 41(2):93-107. PubMed ID: 23680741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Assessment of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Glucocorticoid-induced Diabetes by Continuous Glucose Monitoring.
    Yata Y; Hosojima M; Kabasawa H; Ishikawa T; Kaseda R; Iino N; Suzuki Y; Saito A; Narita I
    Intern Med; 2017 Oct; 56(19):2555-2562. PubMed ID: 28883231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive Hemodialysis and Treatment Complications and Tolerability.
    Morfin JA; Fluck RJ; Weinhandl ED; Kansal S; McCullough PA; Komenda P
    Am J Kidney Dis; 2016 Nov; 68(5S1):S43-S50. PubMed ID: 27772642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidiabetic agents in patients with chronic kidney disease and end-stage renal disease on dialysis: metabolism and clinical practice.
    Abe M; Okada K; Soma M
    Curr Drug Metab; 2011 Jan; 12(1):57-69. PubMed ID: 21303332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoglycemia-Related Hospitalizations and Mortality Among Patients With Diabetes Transitioning to Dialysis.
    Rhee CM; Kovesdy CP; You AS; Sim JJ; Soohoo M; Streja E; Molnar MZ; Amin AN; Abbott K; Nguyen DV; Kalantar-Zadeh K
    Am J Kidney Dis; 2018 Nov; 72(5):701-710. PubMed ID: 30037725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Dose Adjustment of Insulin in Type 2 Diabetes among Hemodialysis Patients with End-Stage Renal Disease: A Randomized Crossover Study.
    Singhsakul A; Supasyndh O; Satirapoj B
    J Diabetes Res; 2019; 2019():6923543. PubMed ID: 31828166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes.
    Satirapoj B; Supasyndh O; Phantana-Angkul P; Ruangkanchanasetr P; Nata N; Chaiprasert A; Kanjanakul I; Choovichian P
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S87-93. PubMed ID: 22043573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sodium balance and the combination of ultrafiltration profile during sodium profiling hemodialysis on the maintenance of the quality of dialysis and sodium and fluid balances.
    Song JH; Park GH; Lee SY; Lee SW; Lee SW; Kim MJ
    J Am Soc Nephrol; 2005 Jan; 16(1):237-46. PubMed ID: 15563561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrafiltration Rate Thresholds in Maintenance Hemodialysis: An NKF-KDOQI Controversies Report.
    Kramer H; Yee J; Weiner DE; Bansal V; Choi MJ; Brereton L; Berns JS; Samaniego-Picota M; Scheel P; Rocco M
    Am J Kidney Dis; 2016 Oct; 68(4):522-532. PubMed ID: 27449697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient's view of dialysis care: development of a taxonomy and rating of importance of different aspects of care. CHOICE study. Choices for Healthy Outcomes in Caring for ESRD.
    Rubin HR; Jenckes M; Fink NE; Meyer K; Wu AW; Bass EB; Levin N; Powe NR
    Am J Kidney Dis; 1997 Dec; 30(6):793-801. PubMed ID: 9398123
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.